Results 151 to 160 of about 477,419 (213)

Predictive modeling of chronic foot ulcer outcomes using longitudinal photoacoustic imaging. [PDF]

open access: yesNpj Imaging
Cheng Y   +11 more
europepmc   +1 more source

Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial [PDF]

open access: yesLancet, The, 2020
BACKGROUND: Buruli ulcer is a neglected tropical disease caused by Mycobacterium ulcerans infection that damages the skin and subcutis. It is most prevalent in western and central Africa and Australia.
Jerome Robert   +2 more
exaly   +5 more sources
Some of the next articles are maybe not open access.

Related searches:

Anastomotic Ulceration

Australian and New Zealand Journal of Surgery, 1969
Seventy‐eight operations on 68 patients with suspected anastomotic ulceration have been analysed. The incidence, investigation, diagnosis and management of this condition are discussed.SummarySeventy‐eight operations on 68 patients with anastomotic ulceration have been assessed. Only 50% of these patients had a completely satisfactory result.
Murray T, Pheils, David J, Gillett
openaire   +3 more sources

Buruli ulcer

Human Vaccines, 2011
Buruli Ulcer (BU) is a neglected, necrotizing skin disease, caused by M. ulcerans, that can leave patients with prominent scars and lifelong disability. M. ulcerans produces a diffusible lipid toxin, mycolactone, essential for bacterial virulence. Prevention is difficult as little is known about disease transmission and there is no vaccine.
Einarsdottir, Thorbjorg, Huygen, Kris
openaire   +2 more sources

Home - About - Disclaimer - Privacy